UWM
AXSM icon

Urban Wealth Management’s Axsome Therapeutics AXSM Stock Holding History

Urban Wealth Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$7K Buy
+181
New +$5.72K 0.02% 220

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Urban Wealth Management's AXSM Position: Q2 2022 in Review

Urban Wealth Management opened a new position in Axsome Therapeutics (AXSM) in Q2 2022: 181 shares worth $7K. The stake represents 0.02% of the portfolio and ranks #220 among its holdings.

174 funds tracked by Wall St. Rank hold AXSM as of Q2 2022.

  • Urban Wealth Management held 181 shares of Axsome Therapeutics worth $7K as of Q2 2022.
  • Axsome Therapeutics was a new Urban Wealth Management position in Q2 2022.
  • Axsome Therapeutics made up 0.02% of Urban Wealth Management's portfolio in Q2 2022, its #220 holding.
  • 174 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2022.

Based on Urban Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.